South-Eastern Asia - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments for Therapeutic or Prophylactic Uses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingSouth-Eastern Asia: Market for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses 2024
Market Size for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in South-Eastern Asia
The Southeast Asian market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses expanded slightly to $X in 2023, increasing by X% against the previous year. Over the period under review, consumption posted prominent growth. Over the period under review, the market attained the peak level in 2023 and is likely to see steady growth in the immediate term.
Production of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in South-Eastern Asia
In value terms, production of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses amounted to $X in 2023 estimated in export price. In general, production, however, showed strong growth. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. Over the period under review, production of hit record highs at $X in 2021; however, from 2022 to 2023, production failed to regain momentum.
Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses
Exports in South-Eastern Asia
In 2023, shipments abroad of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by X% to X tons, falling for the second year in a row after two years of growth. In general, exports, however, enjoyed strong growth. The growth pace was the most rapid in 2021 with an increase of X% against the previous year. As a result, the exports attained the peak of X tons. From 2022 to 2023, the growth of the exports of remained at a lower figure.
In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses contracted sharply to $X in 2023. Overall, exports, however, showed a resilient increase. The growth pace was the most rapid in 2018 with an increase of X% against the previous year. The level of export peaked at $X in 2021; however, from 2022 to 2023, the exports remained at a lower figure.
Exports by Country
Singapore dominates uses structure, reaching X tons, which was near X% of total exports in 2023. Thailand (X tons) followed a long way behind the leaders.
Singapore was also the fastest-growing in terms of the non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exports, with a CAGR of X% from 2012 to 2023. At the same time, Thailand (X%) displayed positive paces of growth. While the share of Singapore (X p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, Singapore ($X) remains the largest non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses supplier in South-Eastern Asia, comprising X% of total exports. The second position in the ranking was held by Thailand ($X), with a X% share of total exports.
From 2012 to 2023, the average annual growth rate of value in Singapore stood at X%.
Export Prices by Country
The export price in South-Eastern Asia stood at $X per ton in 2023, with a decrease of X% against the previous year. Over the period under review, the export price, however, saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2015 an increase of X% against the previous year. Over the period under review, the export prices attained the peak figure at $X per ton in 2018; however, from 2019 to 2023, the export prices failed to regain momentum.
There were significant differences in the average prices amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was Singapore ($X per ton), while Thailand amounted to $X per ton.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Thailand (X%).
Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses
Imports in South-Eastern Asia
After three years of growth, purchases abroad of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses decreased by X% to X tons in 2023. In general, imports continue to indicate a relatively flat trend pattern. The pace of growth appeared the most rapid in 2017 when imports increased by X%. Over the period under review, imports of reached the maximum at X tons in 2012; however, from 2013 to 2023, imports failed to regain momentum.
In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses contracted to $X in 2023. Overall, imports, however, continue to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2020 when imports increased by X% against the previous year. As a result, imports attained the peak of $X. From 2021 to 2023, the growth of imports of remained at a lower figure.
Imports by Country
Thailand represented the key importer of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in South-Eastern Asia, with the volume of imports accounting for X tons, which was approx. X% of total imports in 2023. It was distantly followed by Vietnam (X tons), Malaysia (X tons), Indonesia (X tons), Myanmar (X tons) and the Philippines (X tons), together committing a X% share of total imports. Singapore (X tons) followed a long way behind the leaders.
From 2012 to 2023, the biggest increases were recorded for Myanmar (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, Thailand ($X) constitutes the largest market for imported non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in South-Eastern Asia, comprising X% of total imports. The second position in the ranking was held by Vietnam ($X), with a X% share of total imports. It was followed by Indonesia, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value in Thailand totaled X%. The remaining importing countries recorded the following average annual rates of imports growth: Vietnam (X% per year) and Indonesia (X% per year).
Import Prices by Country
In 2023, the import price in South-Eastern Asia amounted to $X per ton, with a decrease of X% against the previous year. Over the last eleven years, it increased at an average annual rate of X%. The most prominent rate of growth was recorded in 2015 when the import price increased by X%. Over the period under review, import prices attained the peak figure at $X per ton in 2020; however, from 2021 to 2023, import prices failed to regain momentum.
There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Singapore ($X per ton), while Myanmar ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Singapore (X%), while the other leaders experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in South-Eastern Asia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201320 - Other medicaments for therapeutic or prophylactic uses, of HS
Country coverage:
- Brunei Darussalam
- Cambodia
- Indonesia
- Lao People's Democratic Republic
- Malaysia
- Myanmar
- Philippines
- Singapore
- Thailand
- Timor-Leste
- Vietnam
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in South-Eastern Asia, split by region and country
- Trade (exports and imports) in South-Eastern Asia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Brunei Darussalam
- Cambodia
- Indonesia
- Malaysia
- Myanmar
- Philippines
- Singapore
- Thailand
- Timor-Leste
- Vietnam
- Lao People's Democratic Republic
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in China.
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in the EU.
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in Asia.
This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the U.S..
- Molasse Market
- Potassic Fertilizer Market
- Egg, Excluding Hen Egg Market
- Citrus Fruits not Elsewhere Classified Market
- Taro (cocoyam) Market
- Sugar Crop Market
- Spices Except Pepper or Ginger Market
- Coconut, Abaca, Ramie and Other Vegetable Textile Fibre Market
- Yoghurt and Fermented Milk Market
- Toilet, Towel and Tissue Paper Market